Alpha 2.0
Login Register
» Articles » PMID: 29568998

[Cutaneous Side Effects of Targeted Therapies]

Overview
Journal Hautarzt
Specialty Dermatology
Date 2018 Mar 24
PMID 29568998
Citations 1
Authors
H F Merk
C C Zouboulis
Affiliations
Soon will be listed here.
Citing Articles

[Common treatment diagnoses in dermatological emergency services].

Lang V, Scheerer C, Zink A Hautarzt. 2022; 73(2):161-170.

PMID: 35061056 DOI: 10.1007/s00105-021-04930-1.

References
1.
Zouboulis C . Adalimumab for the treatment of hidradenitis suppurativa/acne inversa. Expert Rev Clin Immunol. 2016; 12(10):1015-26. DOI: 10.1080/1744666X.2016.1221762. View
2.
Mockenhaupt M, Paulmann M . [Severe skin reactions due to new medications]. Hautarzt. 2018; 69(4):278-289. DOI: 10.1007/s00105-018-4153-2. View
3.
Subramanian H, Gupta K, Ali H . Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases. J Allergy Clin Immunol. 2016; 138(3):700-710. PMC: 5014572. DOI: 10.1016/j.jaci.2016.04.051. View
4.
Altenburg A, Augustin M, Zouboulis C . [Side effects of biologic therapies in psoriasis]. Hautarzt. 2018; 69(4):290-297. DOI: 10.1007/s00105-018-4156-z. View
5.
Sachs B, Merk H . [Acute hypersensitivity reactions associated with monoclonal antibodies for targeted therapy]. Hautarzt. 2018; 69(4):268-277. DOI: 10.1007/s00105-018-4142-5. View